OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹-9.59 Cr | ₹-7.89 Cr | ₹1.50 Cr | ₹-1.55 Cr | ₹-9.08 Cr |
What is the latest Net Current Assets ratio of OXYGENTA PHARMACEUTICAL ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹-9.59 Cr |
Mar2023 | ₹-7.89 Cr |
Mar2022 | ₹1.50 Cr |
Mar2021 | ₹-1.55 Cr |
Mar2020 | ₹-9.08 Cr |
How is Net Current Assets of OXYGENTA PHARMACEUTICAL Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹-9.59 Cr | Negative | |
Mar2023 | ₹-7.89 Cr | Negative | |
Mar2022 | ₹1.50 Cr | Positive | |
Mar2021 | ₹-1.55 Cr | Negative | |
Mar2020 | ₹-9.08 Cr | - |
Compare Net Current Assets of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹238.8 Cr | -5.1% | -11.4% | -9.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -0.3% | 3.2% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,538.0 Cr | 7.2% | 1.6% | 12.5% | Stock Analytics | |
CIPLA | ₹120,737.0 Cr | -1.3% | -3% | -6.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,723.0 Cr | 0.1% | -1.2% | 1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,025.0 Cr | -1% | -1.3% | -5.9% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -5.1% |
-11.4% |
-9.4% |
SENSEX | 1.9% |
1.3% |
-0.9% |
You may also like the below Video Courses